Tags

Type your tag names separated by a space and hit enter

Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
Mov Disord. 2003 Mar; 18(3):319-23.MD

Abstract

We evaluated the frequency and severity of excessive daytime sleepiness in an outpatient population with Parkinson's disease in comparison to age-matched controls and examined its relationship with antiparkinsonian drug therapy and sleep history. Increased daytime sleepiness and involuntary sleep episodes have been described in Parkinson's disease, but the etiology is not completely understood. The Epworth Sleepiness Scale (ESS), a validated questionnaire for daytime sleepiness, was prospectively administered to 99 consecutive outpatients with Parkinson's disease and 44 age-matched controls. In addition, a short sleep-screening questionnaire was used. The ESS revealed significantly increased daytime sleepiness in PD patients compared to controls (7.5 +/- 4.6 vs. 5.8 +/- 3.0, P = 0.013). The ESS score was abnormally high (10 or more) in 33 % of PD patients and 11.4% of controls (P = 0.001). ESS was not different between PD patients on levodopa monotherapy and those on levodopa and dopamine agonists, or between patients taking ergoline or non-ergoline dopamine agonists. In PD patients and in controls, sleepiness was significantly associated with reported heavy snoring. Increased daytime sleepiness is more frequent in patients with PD than in elderly controls. Similar to controls, increased daytime sleepiness in PD patients is correlated with heavy snoring.

Authors+Show Affiliations

Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12621636

Citation

Högl, Birgit, et al. "Increased Daytime Sleepiness in Parkinson's Disease: a Questionnaire Survey." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 18, no. 3, 2003, pp. 319-23.
Högl B, Seppi K, Brandauer E, et al. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord. 2003;18(3):319-23.
Högl, B., Seppi, K., Brandauer, E., Glatzl, S., Frauscher, B., Niedermüller, U., Wenning, G., & Poewe, W. (2003). Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Movement Disorders : Official Journal of the Movement Disorder Society, 18(3), 319-23.
Högl B, et al. Increased Daytime Sleepiness in Parkinson's Disease: a Questionnaire Survey. Mov Disord. 2003;18(3):319-23. PubMed PMID: 12621636.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. AU - Högl,Birgit, AU - Seppi,Klaus, AU - Brandauer,Elisabeth, AU - Glatzl,Susanne, AU - Frauscher,Birgit, AU - Niedermüller,Ulrike, AU - Wenning,Gregor, AU - Poewe,Werner, PY - 2003/3/7/pubmed PY - 2003/6/18/medline PY - 2003/3/7/entrez SP - 319 EP - 23 JF - Movement disorders : official journal of the Movement Disorder Society JO - Mov Disord VL - 18 IS - 3 N2 - We evaluated the frequency and severity of excessive daytime sleepiness in an outpatient population with Parkinson's disease in comparison to age-matched controls and examined its relationship with antiparkinsonian drug therapy and sleep history. Increased daytime sleepiness and involuntary sleep episodes have been described in Parkinson's disease, but the etiology is not completely understood. The Epworth Sleepiness Scale (ESS), a validated questionnaire for daytime sleepiness, was prospectively administered to 99 consecutive outpatients with Parkinson's disease and 44 age-matched controls. In addition, a short sleep-screening questionnaire was used. The ESS revealed significantly increased daytime sleepiness in PD patients compared to controls (7.5 +/- 4.6 vs. 5.8 +/- 3.0, P = 0.013). The ESS score was abnormally high (10 or more) in 33 % of PD patients and 11.4% of controls (P = 0.001). ESS was not different between PD patients on levodopa monotherapy and those on levodopa and dopamine agonists, or between patients taking ergoline or non-ergoline dopamine agonists. In PD patients and in controls, sleepiness was significantly associated with reported heavy snoring. Increased daytime sleepiness is more frequent in patients with PD than in elderly controls. Similar to controls, increased daytime sleepiness in PD patients is correlated with heavy snoring. SN - 0885-3185 UR - https://www.unboundmedicine.com/medline/citation/12621636/Increased_daytime_sleepiness_in_Parkinson's_disease:_a_questionnaire_survey_ L2 - https://doi.org/10.1002/mds.10365 DB - PRIME DP - Unbound Medicine ER -